ClinicalTrials.govpublic full text
Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes
acute coronary syndrome, inhibition of platelet reactivity, ticagrelor, clopidogrel, pharmacodynamics, pharmacokinetics, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 848403
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.